Over 4000 free audio and video lectures, seminars and teaching resources from Oxford University.
Skip to Content Skip to Navigation

green templeton

# Episode Title Description People Date
1 Creative Commons Uncertainty, risk and decision making in medical care What should patients and clinicians make of uncertainty, risk and decision making in medical care? Dr Angela Coulter delivers a lecture at Green Templeton College as part of the Uncertainty series. Angela Coulter 03 Jul 2012
2 Patient Experience in a Cold Climate: Putting Patients First at a Time of Recession. Panel discussion form Green Templeton College. Joanna Foster, Bruce Laurie, Afl Troughton, Karen Luxford 23 Mar 2012
3 Trusting the News This lecture series seeks to explore and explain the sources and forms of uncertainty in key aspects of contemporary life. Stephen Coleman 24 Mar 2010
4 What's all the fuss about? When individual risks meet policy uncertainties in health This lecture series seeks to explore and explain the sources and forms of uncertainty in key aspects of contemporary life. David Spiegelhalter 24 Mar 2010
5 Is there a healthy future for Big Pharma? Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. John Patterson, Sophia Tickell 04 Feb 2010
6 Is there a healthy future for Big Pharma? Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. John Patterson, Sophia Tickell 04 Feb 2010
7 A Pharma perspective on healthcare needs and innovation in drug discovery The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. Patrick Vallance, Philip Bloomer 09 Jun 2009
8 A Pharma perspective on healthcare needs and innovation in drug discovery The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. Patrick Vallance, Philip Bloomer 09 Jun 2009
9 Pharmaceutical Companies, Government and Society This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment. Sir Michael Rawlins 04 Jun 2009
10 Pharmaceutical Companies, Government and Society This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment. Sir Michael Rawlins 04 Jun 2009
11 Pharmaceutical Industry: Origin and Evolution Tilli Tansey, Professor of History of Modern Medical Sciences, University College London traces the evolution of the modern pharmaceutical industry from the mid nineteenth century to the final decades of the twentieth century. Tilli Tansey 19 May 2009
12 Pharmaceutical Industry: Origin and Evolution Tilli Tansey, Professor of History of Modern Medical Sciences, University College London traces the evolution of the modern pharmaceutical industry from the mid nineteenth century to the final decades of the twentieth century. Tilli Tansey 19 May 2009
13 A Myologist in the House Lord Walton of Detchant gave the 12th annual Alan Emery Lecture at Green Templeton College, Oxford on 5 June 2008. His lecture was entitled "A Myologist in the House". Lord Walton of Detchant 03 Jul 2008